Host Amyn Amlani speaks with Victoria Carr-Brendel, President of Advanced Bionics and Group Vice President (GVP) of Cochlear Implants at Sonova, about the recent advancements in Advanced Bionics' Marvel cochlear implant product and its associated features. Following FDA approval, the company is broadening its Marvel CI product line to include remote programming accessible via patients' smartphones, linked two-ear solutions featuring a CROS device, all aiming to enhance accessibility and outcomes for cochlear implant users.

Moreover, the updated Target CI version 1.5 is designed to improve programming software efficiency for both cochlear implants and hearing instruments, underscoring AB's commitment to advancing hearing care options.

Throughout the discussion, Carr-Brendel highlights how transformative remote programming is and how it aligns with Advanced Bionics' mission to expand hearing care access. She stresses its potential to greatly benefit patients who previously faced barriers due to traditional clinic-based limitations, emphasizing its capacity to boost patient engagement and simplify the programming process for audiologists.

References:

Company website
White paper on AB's remote programming
⁠AB Linked Two-Ear Solutions

Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn and Twitter.

- https://twitter.com/WeekinHearing
- https://www.linkedin.com/company/this-week-in-hearing
- https://hearinghealthmatters.org/thisweek/

Twitter Mentions